Ignite Creation Date:
2024-05-06 @ 5:39 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05387395
Status:
COMPLETED
Last Update Posted:
2022-08-01
First Post:
2022-05-23
Brief Title:
COVID-19 on Disease Activity in Radiologically Isolated Syndrome Cohort
Sponsor:
Centre Hospitalier Universitaire de Nice
Organization:
Centre Hospitalier Universitaire de Nice
Study Overview
Official Title:
Impact of COVID 19 Vaccination or Infection on Disease Activity in Radiologically Isolated Syndrome Cohort the VaxiRIS Study
Status:
COMPLETED
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VaxiRIS
Brief Summary:
The Radiologically Isolated Syndrome RIS is defined as incidental Magnetic Resonance Imaging MRI abnormalities fulfil the criteria for dissemination in space suggestive of multiple sclerosis Nowadays mandatory vaccination in patients with multiple sclerosis MS is widely recommended Regarding COVID19 the absence of specific warnings led to the proposal of vaccination in patients with inflammatory diseases of the central nervous system We aimed to evaluate if COVID19 vaccination or infection increased the risk of clinical conversion to multiple sclerosis or evidence of disease activity EDA in a cohort of RIS subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None